Comparative effects of amitriptyline and amineptine in patients affected by anxious depression
Rampello L, Nicoletti G, Raffaele R, Drago F
Institute of Neurological Sciences,
University of Catania,
School of Medicine,
Italy. Neuropsychobiology 1995; 31(3):130-4


In a double-blind, placebo-controlled study, the therapeutic efficacy of two antidepressants with different neurochemical mechanisms of action, amitriptyline and amineptine, was investigated in patients affected by anxious depression. Sixty-six patients with the primary diagnosis of major depression or bipolar affective disorder (DSM-III-R) and meeting additional operational clinical criteria such as anxiety, trepidation, restlessness, early and/or late insomnia, impulsivity, hostility, dysphoria, compulsivity, hyperperspiration, palpitation, pollakiuria and phobias were included. They were randomly assigned to three groups (n = 22) and treated either with placebo, amitriptyline (up to 100 mg/day) or amineptine (up to 200 mg/day) for 6 weeks. Patients showed better response to amitriptyline, a preferential inhibitor of serotonin reuptake, than to amineptine, a selective inhibitor of dopamine reuptake. The present results suggest that alterations in serotonergic rather than dopaminergic transmission contribute to the pathophysiology of anxious depression.

Amineptne: Italy
Amineptine excess
Amineptine and sex
Mesolimbic dopamine
Amineptine in Portugal
Amineptine v maprotiline
Amineptine v trimipramine
Amineptine v clomipramine
Amineptine and the elderly
Amineptine and smarter dogs

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family